GGrantIndex
← Leaderboards

David J Marcinek

University Of Washington

$9,162,698
Attributed
$12,971,714
Total exposure
17
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,190,408 · 18

By mechanism

R01$5,192,662 · 5
P30$3,420,923 · 2
P01$2,260,258 · 3
R56$1,542,747 · 3
RC2$1,474,777 · 1
R21$965,726 · 2

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Mitochondria

Research focus

MitochondriaInsightAgingTissuesFunctional DisorderOxidative StressAgedMitochondrial DysfunctionIn VivoAge RelatedMusclePublic Health RelevanceMouse ModelLinkAcutePathologyProteinsProductionElectron TransportElderlyBaseOxidation-ReductionResearch PersonnelMuscle Aging

Grant awards (44)

Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)$1,294,617
P30 · FY2025 · AG · contact PI
Biological Mechanisms of Healthy Aging Training Grant$820,315
T32 · FY2025 · AG
Mechanisms underlying reversal of cardiac aging by urolithin a treatment$634,718
R01 · FY2025 · AG · contact PI
Aging Mitochondrial Interactome$534,166
R01 · FY2025 · AG · contact PI
Core A: ADMINISTRATION AND PROGRAM ENRICHMENT$202,229
P30 · FY2025 · AG · contact PI
Nathan Shock Center of Excellence in Basic Biology of Aging$962,037
P30 · FY2024 · AG · contact PI
Mechanisms underlying reversal of cardiac aging by urolithin a treatment$647,672
R01 · FY2024 · AG · contact PI
Aging Mitochondrial Interactome$545,068
R01 · FY2024 · AG · contact PI
Nathan Shock Center of Excellence in Basic Biology of Aging$962,040
P30 · FY2023 · AG · contact PI
Aging Mitochondrial Interactome$545,068
R01 · FY2023 · AG · contact PI
Redox stress resilience in aging skeletal muscle$485,375
R21 · FY2023 · AG · contact PI
Aging Mitochondrial Interactome$361,402
R56 · FY2022 · AG · contact PI
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age$130,563
R01 · FY2022 · ES · contact PI
Structure-function changes in the mitochondrial interactome with age$361,825
R56 · FY2021 · AG · contact PI
Project 2: Mitochondrial ROS in aging-related skeletal muscle aging$299,708
P01 · FY2021 · AG · contact PI
Core E - Magnetic Resonance & Optics Spectroscopy$219,826
P01 · FY2021 · AG · contact PI
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age$130,600
R01 · FY2021 · ES · contact PI
Project 2: Mitochondrial ROS in aging-related skeletal muscle aging$299,708
P01 · FY2020 · AG · contact PI
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age$130,600
R01 · FY2020 · ES · contact PI
Project 2: Mitochondrial ROS in aging-related skeletal muscle aging$299,708
P01 · FY2019 · AG · contact PI
Core E - Magnetic Resonance & Optics Spectroscopy$219,826
P01 · FY2019 · AG · contact PI
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age$130,340
R01 · FY2019 · ES · contact PI
Project 2: Mitochondrial ROS in aging-related skeletal muscle aging$319,340
P01 · FY2018 · AG · contact PI
Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age$130,240
R01 · FY2018 · ES · contact PI
Preventing Skeletal and Cardiac Muscle Aging by Restoring Mitochondrial Function$819,520
R56 · FY2017 · AG
Project 2: Mitochondrial ROS in aging-related skeletal muscle aging$299,303
P01 · FY2017 · AG · contact PI
A novel antibody based biomarker for toxicity of chronic domoic acid exposure$126,632
R01 · FY2016 · ES · contact PI
A novel antibody based biomarker for toxicity of chronic domoic acid exposure$245,871
R01 · FY2015 · ES · contact PI
A novel antibody based biomarker for toxicity of chronic domoic acid exposure$125,551
R01 · FY2014 · ES · contact PI
A novel antibody based biomarker for toxicity of chronic domoic acid exposure$119,140
R01 · FY2014 · ES · contact PI
SS peptides: improve mitochondrial and skeletal muscle function with age$212,875
R21 · FY2013 · AG · contact PI
A novel antibody based biomarker for toxicity of chronic domoic acid exposure$124,366
R01 · FY2013 · ES · contact PI
SS peptides: a new approach to improve mitochondrial and skeletal muscle function$267,476
R21 · FY2012 · AG · contact PI
A novel antibody based biomarker for toxicity of chronic domoic acid exposure$131,942
R01 · FY2012 · ES · contact PI
Mitochondrial-targeted Antioxidants, Aging and AZT in Skeletal Muscle Dysfunction$302,839
P01 · FY2011 · AG · contact PI
Translational Center for In Vivo Mitochondrial Medicine$671,078
RC2 · FY2010 · AG · contact PI
Mitochondrial Dysfunction in Aged Muscle$376,683
R01 · FY2010 · AG · contact PI
Translational Center for In Vivo Mitochondrial Medicine$803,699
RC2 · FY2009 · AG · contact PI
Mitochondrial Dysfunction in Aged Muscle$383,442
R01 · FY2009 · AG · contact PI
Mitochondrial function, oxidative damage, and aging$102,600
K01 · FY2009 · AG · contact PI
Mitochondrial function, oxidative damage, and aging$102,600
K01 · FY2008 · AG · contact PI
Mitochondrial function, oxidative damage, and aging$102,600
K01 · FY2007 · AG · contact PI
Mitochondrial fuction, oxidative damage, and aging$102,600
K01 · FY2006 · AG · contact PI
Mitochondrial function, oxidative damage, and aging$102,600
K01 · FY2005 · AG